Stay updated with breaking news from Forward Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Initiated clinical trials for next generation CAR T candidates, CTX112™ targeting CD19+ B-cell malignancies and CTX131™, targeting CD70+ solid tumors- -Enrollment... | May 8, 2023
Q1 2023 Results Forward-Looking Statement Certain statements in this presentation are "forward-looking statements"... | May 5, 2023
Investor Presentation Quarter Ended March 31, 2023 May 4, 2023 ... | May 4, 2023
Immatics Corporate Presentation May 2, 2023 Delivering the Power of T cells to Cancer Patients ... | May 2, 2023
TORONTO, April 28, 2023 -- Cronos Group Inc. will hold its 2023 Annual Meeting of Shareholders on Thursday, June 22, 2023, at 11:00 a.m. ET. Cronos will be conducting the meeting in a... | April 28, 2023